SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-24-000721
Filing Date
2024-04-12
Accepted
2024-04-12 16:15:52
Documents
17
Period of Report
2024-04-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084176_8k.htm   iXBRL 8-K 32997
2 EXHIBIT 3.1 g084176_ex3-1.htm EX-3.1 6536
6 GRAPHIC ex3-1_pg1.jpg GRAPHIC 77822
7 GRAPHIC ex3-1_pg2.jpg GRAPHIC 250079
8 GRAPHIC ex3-1_pg3.jpg GRAPHIC 38563
  Complete submission text file 0001753926-24-000721.txt   722433

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lipo-20240412.xsd EX-101.SCH 3012
4 XBRL LABEL FILE lipo-20240412_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE lipo-20240412_pre.xml EX-101.PRE 22357
20 EXTRACTED XBRL INSTANCE DOCUMENT g084176_8k_htm.xml XML 3936
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 24841670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)